FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.
Extraction studies demonstrate approaches for evaluating single-use bio-pharmaceutical manufacturing materials.
Extraction studies demonstrate approaches for evaluating single-use bio-pharmaceutical manufacturing materials.
Extraction studies demonstrate approaches for evaluating single-use bio-pharmaceutical manufacturing materials.
Extraction studies demonstrate approaches for evaluating single-use bio-pharmaceutical manufacturing materials.
Those at the top must walk the walk of uncompromising commitment to compliance
Despite different material, agitation, and aeration, the performance of the disposable bioreactor is similar to that of stainless steel bioreactors.
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
The objective of this study was to assess the impact of manufacturing-scale, freeze-thaw conditions on aggregation and subvisible particle formation of a monoclonal antibody solution (mAb-A; IgG1) using a small-scale model.
The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.
The objective of this study was to assess the impact of manufacturing-scale, freeze-thaw conditions on aggregation and subvisible particle formation of a monoclonal antibody solution (mAb-A; IgG1) using a small-scale model.
The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.
Use of a small-scale filler can result in increased filling efficiency.
Opposition to IP protection for COVID-19 vaccines, therapies, tests and other technologies may only prevent eradication and treatment of the disease.
An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
Process controls get some upgrades to better reflect real-time conditions.
Correct organization and appropriate methods for demonstrating biosimilar comparability are important for supporting regulatory filings.
The authors provide insight into microRNA biology, and the simplicity of anti-miR oligonucleotide drug delivery.
Webinar Date/Time: Thu, Jul 10, 2025 11:00 AM EDT
Careful analysis of an unusual precipitate identifies defects.
New study shows China biopharma companies face staffing shortages.
For cellular materials, new ultra scale-down devices inform large-scale downstream processing techniques.
For cellular materials, new ultra scale-down devices inform large-scale downstream processing techniques.
Biomedical researcher shares insights from a career dedicated to advancing therapeutic innovations for unmet medical needs.
FTIR can successfully measure key characteristics of therapeutic proteins in a single step.
FTIR can successfully measure key characteristics of therapeutic proteins in a single step.